A CSIRO research team will spend the next 18 months field-testing its newly developed breath markers for malaria in locations such as Malawi, Bangladesh, Malaysia and Sudan. [ + ]

The CEO of the Australian Nuclear Science and Technology Organisation, Dr Adi Paterson, has been reappointed to his position for the next five years. [ + ]

Senior Cochlear executive Brent Barnes has been appointed the new CEO of technology developer LBT Innovations, commencing on 8 August. [ + ]

Scitech has been appointed an authorised distributor for R&D company PhenoSys, a Berlin-based company that engineers cutting-edge technology for automated animal behaviour research. [ + ]

Avita Medical's ReCell autologous cell harvesting device effectively reduces the occurrence of long-term scarring and itching symptoms associated with paediatric burn treatment and can also be used as a treatment for the skin condition vitiligo. [ + ]

Cynata Therapeutics has had a busy week, announcing a successful patent for its Cymerus mesenchymal stem cell (MSC) technology, a patent application describing certain novel aspects of the technology and the manufacture of its clinical trial product. [ + ]

Scitech has been appointed the authorised distributor for the Photometrics range of cameras and imaging products in Australia and New Zealand. [ + ]

There has been some confusion surrounding the impact of the 2016–17 Budget on the Cooperative Research Centres (CRC) Programme. [ + ]

An international consortium has been awarded a multimillion-dollar research grant from the US government agency Intelligence Advanced Research Projects Activity for research into quantum technology. [ + ]

Orthocell has been granted ethical approval by St Vincent's Hospital Melbourne for a clinical study using its Celgro SMRT Grant collagen scaffold. [ + ]

Scientists have developed a handheld instrument, about the size of a smartphone, that detects Ebola quickly and could be used in remote locations. [ + ]

Scientists believe they can stop Tasmanian devil facial tumour disease using natural antibodies derived from a surprising source — the devil's own immune system. [ + ]

EMBL Australia has announced Professor James Whisstock as its new scientific head and will be holding a showcase in Canberra on 5 July. [ + ]

$15 million of this year's Budget will go towards the National Carp Control Plan — a nationally coordinated approach to eradicating the common carp. [ + ]

Pharmaceutical company IDT Australia has officially opened CMAX Adelaide, claimed to be Australia's largest and most contemporary early-phase clinical trial facility. [ + ]